sukanya sitthikongsak / Royalty-free / Getty Images An effective and more affordable treatment for lung cancer may not gain approval after the Food and Drug Administration (FDA) complained about the lack of black people in its clinical trial, with a top FDA cancer official repeatedly noting in a meeting that it is Black History Month.
Eli Lilly and a Chinese partner called Innovent believe the drug, known as Tyvyt or sintilimab, could extend the lives of those suffering with late-stage non-squamous non-small cell lung cancer (NSCLC), and be more affordable than other treatments. The clinical trial patients were Asian because the trial was conducted in China.
But at a meeting Thursday to decide whether the drug’s application for U.S. approval was satisfactory, Dr. Richard Pazdur, director of the FDA’s Oncology Center of Excellence, said “We just had a meeting yesterday with external groups to celebrate Black History Month and the primary thing that many people said, and I’m sure all of you on this call have heard it, that our clinicians, that our clinicians, we want people that look like us on this trial, okay.”
“I’m very unhappy to have this conversation on this month which is obviously Black History Month. I think we really have to do a better job of this. We have several programs at the FDA on this, including Project Equity, trying to address this issue,” he said.
In the study, called the Orient-11 trial, patients receiving Tyvyt along with chemo reduced disease progression by 52% compared to chemo alone, and reduced the risk of death by 35%. Fierce Pharma noted prior to the meeting that Eli Lilly has made the drug’s affordability a prime selling point, boasting of its “disruptive pricing strategy.”
Padzur said the trial “does not reflect the ethnic and racial make up of a U.S. population […]
They’re Trying to Shut Us Down
Over the last several months, I’ve lost count of how many times the powers-that-be have tried to shut us down. They’ve sent hackers at us, forcing us to take extreme measures on web security. They sent attorneys after us, but thankfully we’re not easily intimidated by baseless accusations or threats. They’ve even gone so far as to make physical threats. Those can actually be a bit worrisome but Remington has me covered.
For us to continue to deliver the truth that Americans need to read and hear, we ask you, our amazing audience, for financial assistance. We have a Giving Fuel page to help us pay the bills. It’s brand new so don’t be discouraged by the lack of donations there. It’s a funny reality that the fewer the donations that have been made, the less likely people are willing to donate to it. One would think this is counterintuitive, but sometimes people are skeptical because they think that perhaps there’s a reason others haven’t been donating. In our situation, we’re just getting started so please don’t be shy if you have the means to help.
Thank you and God bless!